Cenra Inc. (TPE:3716)

Market Cap	4.95B -12.7%
Revenue (ttm)	8.68B -2.8%
Net Income	293.68M -21.0%
EPS	2.65 +6.1%
Shares Out	146.21M
PE Ratio	12.76
Forward PE	n/a
Dividend	1.02 (3.00%)
Ex-Dividend Date	n/a

Volume	147,000
Average Volume	109,261
Open	33.55
Previous Close	33.60
Day's Range	33.20 - 34.00
52-Week Range	29.00 - 39.00
Beta	n/a
RSI	49.13
Earnings Date	Mar 13, 2026

About Cenra

Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It offers active pharmaceutical ingredients, generic drugs for human use, over to the counter drugs, self-care products for the prevention of diseases, home care and cosmetics, and animal healthcare products. The company is also involved in the research and development, contracting manufacturing and international, and senior care services, as well as distributes and sells pharmaceutical brands. In a...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1952
• Employees: 542
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3716

Financial Performance

In 2024, Cenra's revenue was 8.92 billion, an increase of 4.01% compared to the previous year's 8.57 billion. Earnings were 317.35 million, a decrease of -1.53%.